Repertoire Immune Medicines, Inc.

Cambridge, Massachusetts, United States repertoire.com

Overview

Repertoire Immune Medicines, Inc. is a biotechnology company focused on leveraging its platform to develop immune medicines for the prevention, treatment, and cure of cancer, autoimmune disorders, and infectious diseases. The company utilizes its proprietary DECODE platform to explore and harness the full diversity of the immune system to better understand and address complex diseases.

Therapeutic areas

CancerAutoimmune DisordersInfectious Diseases

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Repertoire Immune Medicines, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Cayman Chemical Company
United States
Emory University
United States
Navidea Biopharmaceuticals, Inc.
United States
Vical Incorporated
United States
Angel Pharmaceuticals
China
454 Life Sciences Corporation
United States
ABC Health Research Institute
USA
AC Biotech Incorporated
USA

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo